GlaxoSmithKline Intellectual Property Development Limited
发明人:
Mitchell, James John
申请号：
AU2015338717
公开号：
AU2015338717B2
申请日:
2015.10.29
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Methods of reducing chemical degradant formation, such as those resulting from dimer formation in disulfide bridge-closed ring-bearing polypeptides, such as oxytocin, in a solid-state； to heat stable pharmaceutical compositions having improved physio- or chemical stability, to inhalers and dosage forms of such compositions, to methods of production of and treatment of diseases and or conditions, such as post partum hemhorrage, with such compositions.
